Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes | Diabetology & Metabolic
Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetes - Rayman - 2021 - Diabetic Medicine - Wiley Online Library
The benefit of dexamethasone in patients with COVID‐19 infection is preserved in patients with diabetes - Eng - 2022 - Diabetes, Obesity and Metabolism - Wiley Online Library
Glycemic control following two regimens of antenatal corticosteroids in mild gestational diabetes: a randomized controlled trial | SpringerLink
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions | Nature Reviews Endocrinology
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes | Professor Ketan Dhatariya
Dexamethasone prevents COVID-19 deaths but can cause diabetes-like complications
Effect of Dexamethasone on Glucose Homeostasis In Normal and Prediabetic Subjects With A First-Degree Relative With Type 2 Diabetes Mellitus - Endocrine Practice
Corticosteroid Administration and Impaired Glycemic Control in Mechanically Ventilated COVID-19 Patients - David J. Douin, Martin Krause, Cynthia Williams, Kenji Tanabe, Ana Fernandez-Bustamante, Aurora N. Quaye, Adit A. Ginde, Karsten Bartels, 2022
London COVID-19 dexamethasone and hyperglycaemia: diabetes de-escalation guidance
The Effects of Perioperative Dexamethasone on Glycemic Control and Postoperative Outcomes - ScienceDirect
Dexamethasone, Covd-19, and increased glucose levels
History of diabetes: early science, early treatment, insulin
Dexamethasone and COVID-19 guidance for care home residents with diabetes - Diabetes Professional Care
View of Use of a simplified local guideline improves “front door” management of diabetes and hyperglycaemia in people admitted to hospital with COVID-19 | British Journal of Diabetes
J Endocrinol Metab
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes | Diabetology & Metabolic
Inpatient management of diabetes during the COVID-19 pandemic | Agency for Clinical Innovation
Cancer Research and Treatment
Audit of the identification and management of steroid-induced hyperglycaemia and steroid-induced diabetes - DiabetesontheNet
World Health Organization Philippines - Dexamethasone, a steroid medication, should not be used to self-medicate for COVID-19. It should only be taken when a health professional has assessed the patient's health needs
The effect of anti‐emetic doses of dexamethasone on postoperative blood glucose levels in non‐diabetic and diabetic patients: a prospective randomised controlled study - Tien - 2016 - Anaesthesia - Wiley Online Library
Detecting and Managing Drug-Induced Diabetes
The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis - ScienceDirect
